MedEdge Innovations Unveils New ePTFE Platform and CDMO Services for Medical Implant Applications
This strategic expansion marks a major milestone in MEI’s ongoing mission to provide high-performance, customized medical solutions to device manufacturers worldwide.
Expertise United Around Augmented SBRT – Enhanced Prostate Cancer Treatment with Minimal Side Effects
The seminar brought together some of Europe’s most renowned experts in the field and energized continued development and collaboration to ensure these effective treatment options reach more patients.
Portal Biotech Raises $35 Million Series A | Leveraging AI to Deliver the World’s First Full-Length Single-Molecule Protein Sequencer

Breakthrough proteomics platform technology unlocks full-length protein sequencing and characterisation, accelerating drug development and diagnostics
JLL Partners Announces Investment in Vascular Technology, Incorporated
Vascular Technology, Incorporated is a medical device company specializing in innovative surgical devices and single-use consumables for the operating room.
3 Day How to Write Effective Standard Operating Procedures and Other Process Documents Course | ONLINE EVENT: August 5-7, 2025)
The “How to Write Effective Standard Operating Procedures and Other Process Documents Course” training has been added to ResearchAndMarkets.com’s offering.
The Importance of Relationship Mapping in Salesforce for Sales Success

In this article, we’ll explore how relationship mapping in Salesforce can be a game-changer for sales professionals.
Merck KGaA, Darmstadt, Germany, Honors Alán Aspuru-Guzik with the Heinrich Emanuel Merck Award for Computational Sciences

The Heinrich Emanuel Merck Award has been bestowed upon Alán Aspuru-Guzik, University of Toronto, in recognition of his groundbreaking innovations.
How a Custom Night Guard Can Save You from Costly Dental Procedures Later

A custom night guard is a proactive, protective step you can take now to avoid long-term issues. It’s an act of self-care that pays dividends for years to come.
PRD Therapeutics Announces Initiation of First-in-Human Study for PRD001
This FIH Phase 1 study is designed to evaluate the safety, tolerability, pharmacokinetics, and the signs of early efficacy (LDL-C lowing effect, and liver fat quantitative value using MRI-PDFF) of PRD001 in adult healthy volunteers.
Martin Stumpe Appointed as Chief Technology and AI Officer at Danaher
Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Martin Stumpe will be appointed Chief Technology and AI Officer, effective October 1, 2025. He will report directly to Rainer Blair, President and Chief Executive Officer. This appointment marks a pivotal step in Danaher’s digital transformation and its ambition to […]
Greg Milosevich Appointed EVP, Life Sciences at Danaher
Greg Milosevich joined Danaher in 2010, through the acquisition of Molecular Devices, and since has held roles of increasing responsibility across multiple businesses.
Drug-Free Nasal Spray LUCA V-Defense Creates a Protective Shield Against Viruses and Allergies

Unlike traditional nasal sprays that rely on steroids or antihistamines, LUCA V-Defense forms a non-medicated barrier across the nasal mucosa, the body’s first line of defense against airborne pathogens.